{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:02:48Z","timestamp":1784264568770,"version":"3.55.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"27","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,3]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      The observational association between obesity and atrial fibrillation has been well-established. However, its causal mediators underlying this association remain unclear. This study aimed to investigate the causal relationship between body mass index (BMI), as well as potential mediating factors underlying this association, using Mendelian randomization (MR). Genetically predicted BMI was significantly associated with an increased risk of atrial fibrillation (inverse-variance weighted odds ratio [OR]\u2005=\u20051.350, 95% confidence interval [CI]\u2005=\u20051.268\u20131.436,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001). Sensitivity analyses using multiple methods yielded consistent results, and no evidence of directional pleiotropy was detected after outlier correction. A total of 91 inflammatory cytokines and 4907 plasma proteins were included as potential mediators. Among the screened mediators, SLIT2 exhibited a significant inverse mediating effect on the association between BMI and atrial fibrillation (OR\u2005=\u20051.019, 95% CI\u2005=\u20051.005\u20131.034), accounting for 7% of the total effect. These results suggest that higher BMI is associated with reduced SLIT2 expression, which in turn increases the risk of atrial fibrillation. In contrast, ANGPTL3 showed a significant positive mediating effect (OR\u2005=\u20051.010, 95% CI\u2005=\u20051.003\u20131.017), accounting for 3.64% of the total effect, indicating that elevated BMI increases ANGPTL3 levels, thereby further increasing the risk of atrial fibrillation. This MR study provides genetic evidence supporting a causal association between obesity and atrial fibrillation and suggests that SLIT2 and ANGPTL3 may be involved as mediators linking obesity-related inflammation and lipid dysregulation to atrial fibrillation susceptibility.\n                    <\/jats:p>\n                    <jats:p>First, a 2-sample MR analysis was conducted using genome-wide association studies meta-analysis of European ancestry to estimate the causal effect of genetically proxied BMI on atrial fibrillation. Subsequently, inflammatory cytokines and plasma proteins were considered as candidate mediators, with their cis-protein quantitative trait locus used as instrumental variables. The inverse-variance weighted method was applied as the primary MR approach, while MR-Egger, weighted median, weighted mode, MR-Pleiotropy Residual Sum and Outlier, and leave-one-out methods were used for sensitivity analyses. Shared causal variants were further evaluated using false discovery rate correction and colocalization analysis within a\u2005\u00b1\u2005500\u2009kb window (PPH4\u2005&gt;\u20050.75).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049568","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:01:17Z","timestamp":1783098077000},"page":"e49568","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["SLIT2 and ANGPTL3 as putative mediators linking obesity to atrial fibrillation: A Mendelian randomization study"],"prefix":"10.1097","volume":"105","author":[{"given":"Yanping","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Cardiology, The First College of Clinical Medical Science, China Three Gorges University and Yichang Central People\u2019s Hospital, Yichang, Hubei, China"},{"name":"Institute of Cardiovascular Diseases, China Three Gorges University, Yichang, Hubei, China"},{"name":"Hubei Key Laboratory of Ischemic Cardiovascular Disease, Yichang, Hubei, China"},{"name":"Hubei Provincial Clinical Research Center for Ischemic Cardiovascular Disease, Yichang, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First College of Clinical Medical Science, China Three Gorges University and Yichang Central People\u2019s Hospital, Yichang, Hubei, China"},{"name":"Institute of Cardiovascular Diseases, China Three Gorges University, Yichang, Hubei, China"},{"name":"Hubei Key Laboratory of Ischemic Cardiovascular Disease, Yichang, Hubei, China"},{"name":"Hubei Provincial Clinical Research Center for Ischemic Cardiovascular Disease, Yichang, Hubei, China"},{"name":"Department of Cardiology, Zhongxiang People\u2019s Hospital, Zhongxiang, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First College of Clinical Medical Science, China Three Gorges University and Yichang Central People\u2019s Hospital, Yichang, Hubei, China"},{"name":"Institute of Cardiovascular Diseases, China Three Gorges University, Yichang, Hubei, China"},{"name":"Hubei Key Laboratory of Ischemic Cardiovascular Disease, Yichang, Hubei, China"},{"name":"Hubei Provincial Clinical Research Center for Ischemic Cardiovascular Disease, Yichang, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Medical Record, The First College of Clinical Medical Science, China Three Gorges University and Yichang Central People\u2019s Hospital, Yichang, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyuan","family":"Li","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, The First College of Clinical Medical Science, China Three Gorges University and Yichang Central People\u2019s Hospital, Yichang, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, The First College of Clinical Medical Science, China Three Gorges University and Yichang Central People\u2019s Hospital, Yichang, Hubei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9243-1172","authenticated-orcid":false,"given":"Zhiyang","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First College of Clinical Medical Science, China Three Gorges University and Yichang Central People\u2019s Hospital, Yichang, Hubei, China"},{"name":"Institute of Cardiovascular Diseases, China Three Gorges University, Yichang, Hubei, China"},{"name":"Hubei Key Laboratory of Ischemic Cardiovascular Disease, Yichang, Hubei, China"},{"name":"Hubei Provincial Clinical Research Center for Ischemic Cardiovascular Disease, Yichang, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260709","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines.","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"R2-20260709","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/ijms23010006","article-title":"Atrial fibrillation: pathogenesis, predisposing factors, and genetics.","volume":"23","author":"Sagris","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R3-20260709","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12933-023-01913-5","article-title":"Obesity and atrial fibrillation: a narrative review from arrhythmogenic mechanisms to clinical significance.","volume":"22","author":"Shu","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"R4-20260709","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.3390\/nu16162781","article-title":"Update on obesity and cardiovascular risk: from pathophysiology to clinical management.","volume":"16","author":"Gallo","year":"2024","journal-title":"Nutrients"},{"key":"R5-20260709","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jjcc.2015.04.002","article-title":"Obesity and atrial fibrillation: a comprehensive review of the pathophysiological mechanisms and links.","volume":"66","author":"Goudis","year":"2015","journal-title":"J Cardiol"},{"key":"R6-20260709","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nrcardio.2015.2","article-title":"Inflammation and the pathogenesis of atrial fibrillation.","volume":"12","author":"Hu","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"R7-20260709","doi-asserted-by":"crossref","first-page":"e70103","DOI":"10.1002\/clc.70103","article-title":"Elucidating the linkage between obesity-related body fat indicators and atrial fibrillation: supported by evidence from Mendelian randomization and mediation analyses.","volume":"48","author":"Wang","year":"2025","journal-title":"Clin Cardiol"},{"key":"R8-20260709","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s13679-016-0235-6","article-title":"Effects of obesity on cardiovascular hemodynamics, cardiac morphology, and ventricular function.","volume":"5","author":"Alpert","year":"2016","journal-title":"Curr Obes Rep"},{"key":"R9-20260709","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/CRD.0000000000000490","article-title":"An exploration of the relationship between atrial fibrillation and obesity.","volume":"31","author":"Upadhyay","year":"2023","journal-title":"Cardiol Rev"},{"issue":"Suppl4","key":"R10-20260709","doi-asserted-by":"crossref","first-page":"S511","DOI":"10.33549\/physiolres.934744","article-title":"The effect of obesity, hypertension, diabetes mellitus, alcohol, and sleep apnea on the risk of atrial fibrillation.","volume":"70","author":"\u010carn\u00e1","year":"2021","journal-title":"Physiol Res"},{"key":"R11-20260709","doi-asserted-by":"crossref","DOI":"10.3390\/cells14110839","article-title":"The interplay between pulmonary hypertension and atrial fibrillation: a comprehensive overview.","volume":"14","author":"Sultan","year":"2025","journal-title":"Cells"},{"key":"R12-20260709","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/14779072.2019.1581064","article-title":"Interaction of obesity and atrial fibrillation: an overview of pathophysiology and clinical management.","volume":"17","author":"Pouwels","year":"2019","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"R13-20260709","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euaa214","article-title":"Inflammation and adiposity: new frontiers in atrial fibrillation.","volume":"22","author":"Vyas","year":"2020","journal-title":"Europace"},{"key":"R14-20260709","doi-asserted-by":"crossref","first-page":"1154824","DOI":"10.3389\/fendo.2023.1154824","article-title":"Epicardial adipocytes in the pathogenesis of atrial fibrillation: an update on basic and translational studies.","volume":"14","author":"Willar","year":"2023","journal-title":"Front Endocrinol"},{"key":"R15-20260709","doi-asserted-by":"crossref","first-page":"932262","DOI":"10.3389\/fcvm.2022.932262","article-title":"Epicardial adipose tissue and cardiac arrhythmias: focus on atrial fibrillation.","volume":"9","author":"Conte","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R16-20260709","first-page":"1753","article-title":"Clinical role of epicardial adipose tissue.","volume":"41","author":"Raggi","year":"2025","journal-title":"Can J Cardiol"},{"key":"R17-20260709","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00011-015-0827-8","article-title":"Inflammation, a link between obesity and atrial fibrillation.","volume":"64","author":"Scridon","year":"2015","journal-title":"Inflam Res"},{"key":"R18-20260709","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.3390\/nu14091878","article-title":"Body mass index and the risk of atrial fibrillation: a Mendelian randomization study.","volume":"14","author":"Ma","year":"2022","journal-title":"Nutrients"},{"key":"R19-20260709","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method.","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"R20-20260709","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1093\/eurheartj\/ehad736","article-title":"Mendelian randomization for cardiovascular diseases: principles and applications.","volume":"44","author":"Larsson","year":"2023","journal-title":"Eur Heart J"},{"key":"R21-20260709","doi-asserted-by":"crossref","first-page":"18291","DOI":"10.1073\/pnas.1417426112","article-title":"Fibroblasts secrete Slit2 to inhibit fibrocyte differentiation and fibrosis.","volume":"111","author":"Pilling","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"R22-20260709","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.jhep.2015.07.033","article-title":"Activation of Slit2-Robo1 signaling promotes liver fibrosis.","volume":"63","author":"Chang","year":"2015","journal-title":"J Hepatol"},{"key":"R23-20260709","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/ehf2.13095","article-title":"Crosstalk between the activated Slit2-Robo1 pathway and TGF-\u03b21 signalling promotes cardiac fibrosis.","volume":"8","author":"Liu","year":"2021","journal-title":"ESC Heart Fail"},{"key":"R24-20260709","doi-asserted-by":"crossref","first-page":"102152","DOI":"10.1016\/j.xcrm.2025.102152","article-title":"Effect of complete, lifelong ANGPTL3 deficiency on triglyceride-rich lipoprotein kinetics.","volume":"6","author":"Fappi","year":"2025","journal-title":"Cell Rep Med"},{"key":"R25-20260709","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.tcm.2023.01.008","article-title":"ANGPTL3 inhibition, dyslipidemia, and cardiovascular diseases.","volume":"34","author":"Luo","year":"2024","journal-title":"Trends Cardiovasc Med"},{"key":"R26-20260709","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/CIRCULATIONAHA.123.065866","article-title":"ANGPTL3 deficiency and risk of hepatic steatosis.","volume":"148","author":"D\u2019Erasmo","year":"2023","journal-title":"Circulation"},{"key":"R27-20260709","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jare.2024.05.011","article-title":"ANGPTL3 accelerates atherosclerotic progression via direct regulation of M1 macrophage activation in plaque.","volume":"70","author":"Zhang","year":"2025","journal-title":"J Adv Res"},{"key":"R28-20260709","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s11883-022-01071-1","article-title":"ANGPTL3 as a drug target in hyperlipidemia and atherosclerosis.","volume":"24","author":"Mohamed","year":"2022","journal-title":"Curr Atheroscler Rep"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049568","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:01:43Z","timestamp":1783616503000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":28,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049568","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"2025-12-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}